RE:ViaCyteBioTeck wrote: Just when we thought they were teets up, they may beat us at getting stem cells in a device into a body. Whether it works or not is another story but A for effort. Partnered with CRISPR for immuno suppression gene editing which sounds like won't be in the clinic this year. https://www.med.ubc.ca/news/b-c-researchers-launching-clinical-trial-for-first-genetically-engineered-stem-cell-based-therapy-for-type-1-diabetes/
Viacycte lol...... it is in Canada with limited money . Funny how Vertex and Viacycte are doing trials in Canada ... it's like being on the Venture exchange .
Fda is the gold standard. To get any recognition by pharma and worldwide acceptance Fda and US trials are crtitical .
Viacytes original trial did not fair well with limited c peptide production . So the fact the competition is starting to use devices now validates Sva scientific program. Note there is no major funding form any pharma's for this $ 1 million Canadian trial at UBC.
Hopefully Sva can announce Thyroid trial at UBC soon.
MS